Laurion Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-42,829
Closed -$940K 1192
2019
Q2
$940K Buy
+42,829
New +$940K 0.01% 584
2019
Q1
Sell
-1,260,854
Closed -$15.9M 1151
2018
Q4
$15.9M Buy
+1,260,854
New +$18.8M 0.28% 88
2016
Q2
Sell
-17,500
Closed -$118K 953
2016
Q1
$118K Buy
+17,500
New +$115K ﹤0.01% 715

Other funds holding NEO

Laurion Capital Management's NEO Position: Q3 2019 in Review

Laurion Capital Management sold out of NeoGenomics (NEO) in Q3 2019, closing a stake of 42,829 shares — an estimated $940K sold.

Laurion Capital Management first reported a position in NEO in Q1 2016 and held it in 3 quarters. The position peaked at $15.9M in Q4 2018. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

  • Laurion Capital Management reported no remaining NeoGenomics position as of Q3 2019 after selling out during the quarter.
  • Laurion Capital Management sold 42,829 NeoGenomics shares in Q3 2019, an estimated $940K.
  • Laurion Capital Management first reported a position in NeoGenomics in Q1 2016 and held it in 3 quarters.
  • Laurion Capital Management's NeoGenomics position peaked at $15.9M in Q4 2018.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Laurion Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.